These processes are likely to be highly significant to in vivo folate homoeostasis, and indeed may contribute to pathophysiologic conditions associated with folate deficiency and/or impact therapeutic efficacy of standard and targeted antifolates for cancer.
← all excerpts
Post-transcriptional regulation of the human reduced folate carrier as a novel adaptive mechanism in response to folate excess or deficiency.
1
—
—